EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 178 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2017. The put-call ratio across all filers is 1.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,714,000 | -45.6% | 19,133 | -37.2% | 0.42% | -36.5% |
| Q3 2020 | $3,150,000 | -53.0% | 30,483 | -64.1% | 0.66% | -50.7% |
| Q2 2020 | $6,705,000 | +17.1% | 84,793 | -14.3% | 1.34% | +50.5% |
| Q1 2020 | $5,726,000 | -17.4% | 98,970 | -31.0% | 0.89% | +79.2% |
| Q2 2019 | $6,933,000 | -63.0% | 143,509 | -61.3% | 0.50% | -63.6% |
| Q1 2019 | $18,728,000 | -99.9% | 370,713 | -0.2% | 1.36% | -23.5% |
| Q4 2018 | $22,024,892,000 | -10.3% | 371,540 | -0.4% | 1.78% | +12.4% |
| Q3 2018 | $24,553,274,000 | +43.1% | 372,980 | +9.8% | 1.58% | +27.6% |
| Q2 2018 | $17,156,452,000 | -7.4% | 339,799 | -3.4% | 1.24% | -10.6% |
| Q1 2018 | $18,523,850,000 | +22.7% | 351,830 | +8.3% | 1.39% | +18.1% |
| Q4 2017 | $15,098,614,000 | +20.3% | 324,911 | +4.7% | 1.18% | +10.1% |
| Q3 2017 | $12,547,833,000 | +40.8% | 310,206 | +18.1% | 1.07% | +29.5% |
| Q2 2017 | $8,909,547,000 | +19.1% | 262,741 | +2.0% | 0.82% | +12.0% |
| Q1 2017 | $7,482,621,000 | +0.1% | 257,666 | +13.2% | 0.74% | -12.5% |
| Q4 2016 | $7,477,241,000 | +8.0% | 227,687 | +3.7% | 0.84% | +10.2% |
| Q3 2016 | $6,925,060,000 | +17.4% | 219,634 | +4.7% | 0.76% | -4.9% |
| Q2 2016 | $5,899,689,000 | -22.5% | 209,804 | +0.1% | 0.80% | -24.6% |
| Q1 2016 | $7,615,943,000 | -4.2% | 209,517 | +5.4% | 1.06% | -10.5% |
| Q4 2015 | $7,953,188,000 | +59.2% | 198,780 | +13.3% | 1.19% | +16.1% |
| Q3 2015 | $4,996,833,000 | +48.9% | 175,389 | +72.2% | 1.02% | +6.3% |
| Q2 2015 | $3,355,760,000 | +54.8% | 101,844 | +35.1% | 0.96% | +46.1% |
| Q1 2015 | $2,167,929,000 | -3.6% | 75,380 | -8.7% | 0.66% | -33.2% |
| Q4 2014 | $2,247,891,000 | +24.1% | 82,552 | -2.9% | 0.99% | +18.5% |
| Q3 2014 | $1,811,414,000 | -5.9% | 85,003 | -0.9% | 0.83% | -2.9% |
| Q2 2014 | $1,925,855,000 | +7.2% | 85,746 | +20.6% | 0.86% | -19.3% |
| Q1 2014 | $1,797,101,000 | +102008.0% | 71,116 | -7.1% | 1.06% | -2.0% |
| Q4 2013 | $1,760,000 | +128.3% | 76,537 | +89.1% | 1.08% | +67.5% |
| Q3 2013 | $771,000 | +53.3% | 40,466 | +16.0% | 0.65% | +27.4% |
| Q2 2013 | $503,000 | – | 34,899 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |